Other Headlines

Former Trade Desk pro from Siemens joins the DOTmed 100 company.
Gary Lee of DMS Topline Medical took some time to sit down with DOTmed News during the recent North Carolina Biomedical Association (NCBA).
The Canadian maker of high-end interventional MR suites acquires a prototype neurosurgery robot designed with aerospace technology in exchange for 1.6 million shares.
Two Idaho clinics are the latest to install NovaRad's NovaPACS to improve workflow and ease image access for interpreting and referring physicians.
CHEM certification course helps train healthcare environmental safety and security managers.

Have News for Us?

Submit your news on the industry, people, or companies.

Forward to a Friend

More Industry Headlines

New Research Study Will Use fMRIs to Examine Soldiers' TBIs Research on traumatic brain injury will be used to determine faster treatment, safer vehicles.

Congress Submits Bill to Repeal Antitrust Exemption Reform measure would end exemption for health care, medical malpractice insurance.

White House to Convene Health Meeting President Obama promised a bipartisan event Feb. 25.

FDA Issues Guidance on Facilitating Medical Device Clinical Trials Agency suggests statistical methods for cost and streamlining.

Las Vegas Spine Surgeon Pleads Guilty to Misprision of Felony A federal case review from the pages of DOTmed Business News.

Philips Inks Three-Year Deal With SunCrest Philips' telemedicine division inked a three-year deal with the Sun Belt home care system SunCrest Healthcare, Inc.

HHS Highlights Health Care Investments in New Budget Budget includes health IT, research, public health measures.

Colorado Physicians Group Settles With FTC Over Alleged Price-Fixing Group accused of anti-competitive tactics against health insurers.

FDA Wants $4 Billion to Overhaul Medical Device, Food Safety Monitoring The injections of new cash could help establish a registry for medical devices and create over 1,000 new jobs.

NIH Discusses Dose Monitoring Program DOTmed News spoke with Dr. David Bluemke of the National Institutes of Health about the new program to require radiation dose monitoring on all equipment purchased by the NIH's Clinical Center.

The Optiscan Five
pen microscope

Pen-Sized Microscope Aims for Precise Brain Surgeries

by Brendon Nafziger, Writer
A laser microscope that picks up fluorescently-dyed cells could result in more precise tumor extraction during brain surgery, and streamlined workflows in the operating room.

According to a study published recently in the Journal of Neurosurgery, neurosurgeons at the Barrow Neurological Institute at St. Joseph's Hospital and Medical Center in Phoenix, Ariz. found that the pen-sized microscope could help them precisely identify where tumor tissue ends and healthy tissue begins.

The microscope works by letting doctors detect the edges of cancerous tissue at the cellular level. The cancerous tissue is distinguished from healthy tissue by fluorescent dyes, which selectively tag the non-healthy growths.

"There are a couple problems in the OR with respect to malignant brain tumors," Mark Preul, M.D., the director of the Neurosurgery Research Laboratory at Barrow Institute, tells DOTmed News. "One, the tumors are infiltratives so you don't exactly know their margins. You can image these things, but it doesn't give you a look at the actual cellular dimensions."

That's why in surgeries, while the patient lies with his head open, the surgeons will send samples of the tissue to the neuropathologist's lab so they can determine if the doctor managed to completely excise the lesion. But usually, this process takes about 40 minutes.

"The tissue has got to be mounted, stained, looked at; a report has to go back to the OR," says Dr. Preul. "There's a real workflow problem."

Plus, Dr. Preul says with frozen cutting-sections, you can get visual artifacts that can impede proper diagnosis, and can sometimes lead to mis-classification of tumor aggressiveness. As a surgeon, "you will tailor surgery according to pathological interpretations," he says, so it's important to know what sort of growth they're dealing with.

But with the device, known as a confocal microscope, working in conjunction with brain-safe dyes, Dr. Preul hopes doctors can accurately learn, on-the-fly, the extent of a tumor's growth, so they can easily, quickly and completely cut it out.

Finding brain-friendly fluorescent dyes

The laser microscope was developed by Optiscan, an Adelaide, Australia based company, which is collaborating with Carl Zeiss, a storied German optics firm out of Oberkochen, Germany.

Although it has been used in GI endoscopies for the past couple of years, it has only recently been applied to brain surgeries. One reason for the delay had been concern over fluorescent dyes.

"In the brain, there aren't many fluorescent markers that have been approved by the FDA for use," says Dr. Preul. The problem is that many fluorescent markers are suspected of damaging cellular DNA, says Dr. Preul. This isn't so much of a problem in the gut, where there's rapid tissue turnover around every two days, he says; but the brain works differently, so caution has to be used in anything introduced.

Although some safer dyes had been applied to the brain, they tended to also light up masses of surrounding blood cells, making distinguishing between tumor cells and blood cells difficult for the microscope, Dr. Preul says.

The answer appears to be a dye called 5-Aminolevulinic acid, or 5-ALA. "The 5 ALA really only lights up tumor cells," says Dr. Preul. "It's like having a topical fluorophor, except it doesn't light up erythrocytes [red blood cells]. All you see are the tumor cells."

Opening salvos

5-ALA is currently being tested in around six investigative centers in the U.S., and does not have FDA approval.

Also, the microscope technique is only in the early stages. According to Dr. Preul, only about 30 or 40 patients have had the procedure done on them.

"We're going to have years worth of work," says Dr. Preul, "where you acquire patients and then you gauge their surgical resection with the Optiscan versus surgical resection without it."

"We're only at the opening salvos," he adds.



Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

Please Send us your Comments.

Printable Story
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2010 DOTmed.com, Inc.
ALL RIGHTS RESERVED